Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Case report

Novel mutation of the PRNPgene of a clinical CJD case

Authors: Konstantia Kotta, Ioannis Paspaltsis, Sevasti Bostantjopoulou, Helen Latsoudis, Andreas Plaitakis, Dimitrios Kazis, John Collinge, Theodoros Sklaviadis

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Transmissible spongiform encephalopathies (TSEs), a group of neurodegenerative diseases, are thought to be caused by an abnormal isoform of a naturally occurring protein known as cellular prion protein, PrPC. The abnormal form of prion protein, PrPSc accumulates in the brain of affected individuals. Both isoforms are encoded by the same prion protein gene (PRNP), and the structural changes occur post-translationally. Certain mutations in the PRNP gene result in genetic TSEs or increased susceptibility to TSEs.

Case presentation

A 70 year old woman was admitted to the hospital with severe confusion and inability to walk. Relatives recognized memory loss, gait and behavioral disturbances over a six month period prior to hospitalization. Neurological examination revealed Creutzfeldt-Jakob disease (CJD) related symptoms such as incontinence, Babinski sign and myoclonus. EEG showed periodic sharp waves typical of sporadic CJD and cerebrospinal fluid analysis (CSF) was positive for the presence of the 14-3-3-protein. As the disease progressed the patient developed akinetic mutism and died in the tenth month after onset of the disease symptoms. Unfortunately, no autopsy material was available. PRNP sequencing showed the occurrence of a point mutation on one allele at codon 193, which is altered from ACC, coding for a threonine, to ATC, encoding an isoleucine (T193I).

Conclusion

Here we report a novel mutation of the PRNP gene found in an elderly female patient resulting in heterozygosity for isoleucine and threonine at codon 193, in which normally homozygosity for threonine is expected (T193). The patient presented typical clinical symptoms of CJD. EEG findings and the presence of the 14-3-3 protein in the CSF, contributed to CJD diagnosis, allowing the classification of this case as a probable CJD according to the World Health Organization (WHO) accepted criteria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science. 1982, 216 (4542): 136-144. 10.1126/science.6801762.CrossRefPubMed Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science. 1982, 216 (4542): 136-144. 10.1126/science.6801762.CrossRefPubMed
2.
go back to reference Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C: Mice devoid of PrP are resistant to scrapie. Cell. 1993, 73 (7): 1339-1347. 10.1016/0092-8674(93)90360-3.CrossRefPubMed Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C: Mice devoid of PrP are resistant to scrapie. Cell. 1993, 73 (7): 1339-1347. 10.1016/0092-8674(93)90360-3.CrossRefPubMed
3.
go back to reference Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SG: Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A. 2000, 97 (18): 10168-10172. 10.1073/pnas.97.18.10168.CrossRefPubMedPubMedCentral Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SG: Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A. 2000, 97 (18): 10168-10172. 10.1073/pnas.97.18.10168.CrossRefPubMedPubMedCentral
4.
go back to reference Peoc'h K, Guerin C, Brandel JP, Launay JM, Laplanche JL: First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett. 2000, 286 (2): 144-148. 10.1016/S0304-3940(00)01100-9.CrossRefPubMed Peoc'h K, Guerin C, Brandel JP, Launay JM, Laplanche JL: First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett. 2000, 286 (2): 144-148. 10.1016/S0304-3940(00)01100-9.CrossRefPubMed
5.
go back to reference Tranchant C, Geranton L, Guiraud-Chaumeil C, Mohr M, Warter JM: Basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Neurology. 1999, 52 (6): 1244-1249.CrossRefPubMed Tranchant C, Geranton L, Guiraud-Chaumeil C, Mohr M, Warter JM: Basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Neurology. 1999, 52 (6): 1244-1249.CrossRefPubMed
6.
go back to reference Brandel JP: Clinical aspects of human spongiform encephalopathies, with the exception of iatrogenic forms. Biomed Pharmacother. 1999, 53 (1): 14-18. 10.1016/S0753-3322(99)80055-9.CrossRefPubMed Brandel JP: Clinical aspects of human spongiform encephalopathies, with the exception of iatrogenic forms. Biomed Pharmacother. 1999, 53 (1): 14-18. 10.1016/S0753-3322(99)80055-9.CrossRefPubMed
7.
go back to reference Prusiner SB, Telling G, Cohen FE, DeArmond SJ: Prion diseases of humans and animals. Seminars in Virology. 1996, 7 (15): 159-173. 10.1006/smvy.1996.0021.CrossRef Prusiner SB, Telling G, Cohen FE, DeArmond SJ: Prion diseases of humans and animals. Seminars in Virology. 1996, 7 (15): 159-173. 10.1006/smvy.1996.0021.CrossRef
8.
go back to reference Prusiner SB, Scott MR: Genetics of prions. Annu Rev Genet. 1997, 31: 139-175. 10.1146/annurev.genet.31.1.139.CrossRefPubMed Prusiner SB, Scott MR: Genetics of prions. Annu Rev Genet. 1997, 31: 139-175. 10.1146/annurev.genet.31.1.139.CrossRefPubMed
9.
go back to reference Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E: Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118 (2): 166-174. 10.1007/s00439-005-0020-1.CrossRefPubMed Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E: Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118 (2): 166-174. 10.1007/s00439-005-0020-1.CrossRefPubMed
10.
go back to reference Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H: Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002, 249 (11): 1567-1582. 10.1007/s00415-002-0896-9.CrossRefPubMed Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H: Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002, 249 (11): 1567-1582. 10.1007/s00415-002-0896-9.CrossRefPubMed
11.
go back to reference Ladogana A, Puopolo M, Poleggi A, Almonti S, Mellina V, Equestre M, Pocchiari M: High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology. 2005, 64 (9): 1592-1597. 10.1212/01.WNL.0000160118.26865.11.CrossRefPubMed Ladogana A, Puopolo M, Poleggi A, Almonti S, Mellina V, Equestre M, Pocchiari M: High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology. 2005, 64 (9): 1592-1597. 10.1212/01.WNL.0000160118.26865.11.CrossRefPubMed
12.
go back to reference Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Ruther E, Aitken A: Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem. 1999, 73 (6): 2485-2490. 10.1046/j.1471-4159.1999.0732485.x.CrossRefPubMed Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Ruther E, Aitken A: Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem. 1999, 73 (6): 2485-2490. 10.1046/j.1471-4159.1999.0732485.x.CrossRefPubMed
13.
go back to reference WHO: Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. 1998 WHO: Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. 1998
14.
go back to reference Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000, 55 (6): 811-815.CrossRefPubMed Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000, 55 (6): 811-815.CrossRefPubMed
15.
go back to reference Sanchez-Valle R, Nos C, Yague J, Graus F, Dominguez A, Saiz A: Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol. 2004, 11 (10): 649-655. 10.1111/j.1468-1331.2004.00967.x.CrossRefPubMed Sanchez-Valle R, Nos C, Yague J, Graus F, Dominguez A, Saiz A: Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol. 2004, 11 (10): 649-655. 10.1111/j.1468-1331.2004.00967.x.CrossRefPubMed
16.
go back to reference Palmer MS, Dryden AJ, Hughes JT, Collinge J: Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991, 352 (6333): 340-342. 10.1038/352340a0.CrossRefPubMed Palmer MS, Dryden AJ, Hughes JT, Collinge J: Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991, 352 (6333): 340-342. 10.1038/352340a0.CrossRefPubMed
17.
go back to reference Plaitakis A, Viskadouraki AK, Tzagournissakis M, Zaganas I, Verghese-Nikolakaki S, Karagiorgis V, Panagiotides I, Kilindireas C, Patsouris E, Haberler C, Budka H, Sklaviadis T: Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol. 2001, 50 (2): 227-233. 10.1002/ana.1285.CrossRefPubMed Plaitakis A, Viskadouraki AK, Tzagournissakis M, Zaganas I, Verghese-Nikolakaki S, Karagiorgis V, Panagiotides I, Kilindireas C, Patsouris E, Haberler C, Budka H, Sklaviadis T: Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol. 2001, 50 (2): 227-233. 10.1002/ana.1285.CrossRefPubMed
18.
go back to reference Saetta AA, Michalopoulos NV, Malamis G, Papanastasiou PI, Mazmanian N, Karlou M, Kouzoupis A, Korkolopoulou P, Patsouris E: Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol. 2006, 21 (3): 211-215. 10.1007/s10654-006-0012-z.CrossRefPubMed Saetta AA, Michalopoulos NV, Malamis G, Papanastasiou PI, Mazmanian N, Karlou M, Kouzoupis A, Korkolopoulou P, Patsouris E: Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol. 2006, 21 (3): 211-215. 10.1007/s10654-006-0012-z.CrossRefPubMed
19.
go back to reference van Rheede T, Smolenaars MM, Madsen O, de Jong WW: Molecular evolution of the mammalian prion protein. Mol Biol Evol. 2003, 20 (1): 111-121. 10.1093/molbev/msg014.CrossRefPubMed van Rheede T, Smolenaars MM, Madsen O, de Jong WW: Molecular evolution of the mammalian prion protein. Mol Biol Evol. 2003, 20 (1): 111-121. 10.1093/molbev/msg014.CrossRefPubMed
20.
go back to reference Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G, Wuthrich K: NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A. 2000, 97 (1): 145-150. 10.1073/pnas.97.1.145.CrossRefPubMedPubMedCentral Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G, Wuthrich K: NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A. 2000, 97 (1): 145-150. 10.1073/pnas.97.1.145.CrossRefPubMedPubMedCentral
21.
go back to reference Collins S, Boyd A, Fletcher A, Byron K, Harper C, McLean CA, Masters CL: Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch Neurol. 2000, 57 (7): 1058-1063. 10.1001/archneur.57.7.1058.CrossRefPubMed Collins S, Boyd A, Fletcher A, Byron K, Harper C, McLean CA, Masters CL: Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch Neurol. 2000, 57 (7): 1058-1063. 10.1001/archneur.57.7.1058.CrossRefPubMed
22.
go back to reference Peoc'h K, Manivet P, Beaudry P, Attane F, Besson G, Hannequin D, Delasnerie-Laupretre N, Laplanche JL: Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum Mutat. 2000, 15 (5): 482-10.1002/(SICI)1098-1004(200005)15:5<482::AID-HUMU16>3.0.CO;2-1.CrossRefPubMed Peoc'h K, Manivet P, Beaudry P, Attane F, Besson G, Hannequin D, Delasnerie-Laupretre N, Laplanche JL: Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum Mutat. 2000, 15 (5): 482-10.1002/(SICI)1098-1004(200005)15:5<482::AID-HUMU16>3.0.CO;2-1.CrossRefPubMed
Metadata
Title
Novel mutation of the PRNPgene of a clinical CJD case
Authors
Konstantia Kotta
Ioannis Paspaltsis
Sevasti Bostantjopoulou
Helen Latsoudis
Andreas Plaitakis
Dimitrios Kazis
John Collinge
Theodoros Sklaviadis
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-169

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine